2019
Resuming chemotherapy after interval cytoreductive surgery in ovarian cancer: The impact of time and temperature
Clark M, Kollara A, May T, Brown T. Resuming chemotherapy after interval cytoreductive surgery in ovarian cancer: The impact of time and temperature. Gynecologic Oncology 2019, 154: 55-56. DOI: 10.1016/j.ygyno.2019.04.133.Peer-Reviewed Original Research
2018
Investigating the time intervals between primary cytoreductive surgery and initiation of adjuvant chemotherapy in patients with advanced epithelial ovarian cancer who had optimal cytoreduction surgery with bowel resection
Lee Y, Lee J, Paik E, Clark M, Kim R, Brown T, May T. Investigating the time intervals between primary cytoreductive surgery and initiation of adjuvant chemotherapy in patients with advanced epithelial ovarian cancer who had optimal cytoreduction surgery with bowel resection. Gynecologic Oncology 2018, 149: 98. DOI: 10.1016/j.ygyno.2018.04.226.Peer-Reviewed Original ResearchDoes the time interval off neoadjuvant chemotherapy before and after interval debulking surgery affect the overall survival of women with advanced-epithelial ovarian cancer?
Clark M, Lee Y, Xu W, Brown T, May T. Does the time interval off neoadjuvant chemotherapy before and after interval debulking surgery affect the overall survival of women with advanced-epithelial ovarian cancer? Gynecologic Oncology 2018, 149: 92. DOI: 10.1016/j.ygyno.2018.04.210.Peer-Reviewed Original Research